There seems more meat to the US documents aimed at patients, 10 although the societies at the time of writing have provided fewer than 90 of these. They are generally highly informative and clear. The leaflet on heartburn (American Gastroenterological Association) 11 discourages the use of proton pump inhibitors (PPIs), and advocates antacids or H 2 -antagonists, with a clear listing of the admittedly low incidence of side effects to PPIs. However, it is notable that in many of the leaflets the basis of funding assumed is 'fee-forservice', and it is striking how this enhances the persuasiveness of the leaflet. The prescription drug price of PPI therapy is pointed out as being approximately $300 per month more than antacids. The patient leaflet on the pros and cons of prostate specific antigen testing (American Academy of Family Physicians), 12 after a clear exposition of the low specificity of the test for cancer, the other potential causes of elevation and the indolent nature of many instances of the tumour, moves to point out how rapidly costs escalate -consultation, ultrasound, other professional fees and biopsy. The Academy of Neurology's patient advice (only two patient leaflets at the time of writing) 13 covers migraine drugs to avoid, and the pros and cons of carotid artery surgery; the latter flags up uncertain outcomes and highlights both 'the surgery has serious risks' and 'the surgery can cost a lot…may or may not be covered by your insurance'. Money talks, and in that regard, if no other, the lack of direct cost to the patient for most NHS transactions may reduce the impact of the patient educational approach.
There seem to be messages here for how the AoMRC should pursue the Choosing Wisely initiative in the UK. Certainly on first glance, producing and promulgating material for patient education seems likely to be more effective in changing expectations of treatment and therefore practice, than promulgation of what in many cases seem rather self-evident top 5 recommendations for doctors. There is in any case already a compilation of 'do not do' recommendations from NICE guidance.
14 However, the unspoken leitmotif to all the patient information leaflets is the necessity to spend more time in explanation and discussion with patients.
There are also other strings to the AoMRC's bow. In parallel to the Choosing Wisely initiative, the AoMRC produced a long document last year -Protecting resources, promoting value: a doctor's guide to cutting waste in clinical care. 15 While not attempting to quantify how much money in total the NHS might save by cutting waste, it points out in substantial detail and with costed examples how relatively simple changes can prevent waste, save money and indeed reduce the carbon footprint of the NHS. The document suggests a concentration
